Z.Chrzanowska-Lightowlers@ncl.ac.uk
-2 -
Abstract
Human mitochondria are not strict adherents to the universal genetic code with modifications that include the apparent recoding of 2 arginine triplets to termination signals. This use of both AGA and AGG occurs rarely in other mammals and the precise mechanism that has driven the change from encoding arginine to dictating a translational stop has posed a challenging conundrum. Sequence data reveals that a -1 frameshift of the mitoribosome upstream of the rare codons would necessitate the recognition of only the conventional UAA and UAG termination codons. With the use of a sequence specific endoribonuclease we show that the rare arginine codons presumably in association with other cis-elements do indeed promote frameshifting in human mitoribosomes.
Following the sequencing of human mtDNA, it has been generally accepted that AGA and AGG have been recoded as stop signals (1) . It was further assumed that an accommodation by mitochondrial release factor(s) must have occurred to ensure sequence specific recognition of these non-cognate stop codons (2) . Closer inspection of the mt-genome sequence shows that the AGA/AGG codons that are predicted to terminate the 2 open reading frames, MTCO1 and MTND6 respectively, are both immediately downstream of a U residue. It is therefore possible that although these 2 codons do function in the terminal stage of translation, this role is primarily to stall the mitoribosome, causing a ribosomal frameshift on the human mt-mRNA. In contrast to any current mitochondrial examples this frameshift would be in the -1 direction and not in the protein coding region. Further, no modifications to release factors would need to have evolved.
As a consequence of a -1 ribosomal frameshift, both of the open reading frames (ORFs) would terminate in the standard UAG codon and thereby follow the same '2 stop codon' (UAA, UAG) mechanism common to many other mitochondrial gene expression systems (3). Frameshifting in either direction has never been reported in the expression of mammalian mtDNA, although limited examples of classical +1 Programmed Ribosome Frameshifting (PRF) have been postulated or documented in other species. The ostrich -3 -nad3 gene, for example, was reported to encode only a truncated protein (4), but after examining sequences from a number of bird and turtle species, Mindell et al (5) noticed that only a single base insertion was responsible for the interruption of the ORF, resulting in a premature stop. It was, therefore, postulated that mitochondrial translation must invoke a +1 PRF. More recently, other studies have identified common single nucleotide insertions in the protein coding regions of a subset of mitochondrial genes from diverse species including oyster, glass sponge and ants (described in 6). All would require a similar +1 PRF for faithful production of the protein. It has led to the hypothesis that although rare, this +1 PRF mechanism must be tolerated in specific mitochondrial translation systems from a wide range of organisms (6) . The examples above described nucleic acid sequences that would predict the need for +1PRF to complete accurate mitochondrial protein synthesis.
This contrasts with human mt-mRNA where all the coding sequences are known to be uninterrupted. However, we propose that human mitoribosomes do invoke -1 frameshift but at the stop codon after the proteins have been synthesised to completion, to allow recognition by the release factor and facilitate release of the nascent polypeptide.
Is -1 ribosomal frameshifting supported by analysis of human mt-mRNA ? Particular
features that promote classical frameshifting have been well characterised in other translation systems. One of the most commonly conserved is a ribosome that has paused or stalled as a consequence of either a rare or slowly decoded codon, or an inhibitory secondary structure (7) (8) (9) . Precisely such paused mitoribosomes would be generated on human mt-mRNA by both AGA and AGG triplets, as no mt-tRNAs exist that recognize these codons. Further, these identical rare codons behave as 'hungry codons' in other translational systems under conditions of arginine deficiency, triggering a pause in translation and stimulating a -1 frameshift (8, 9) .
Two further common features that promote -1 frameshifting are an upstream heptapeptide 'slippery sequence' and a downstream sequence that can generate a stable secondary structure such as a stem loop or pseudoknot (7) . These features in the context of human mitochondrial MTCO1 and MTND6 transcripts are discussed below (Fig 1) .
The upstream slippery sequence has been best characterised in viruses where the -1 frameshift is a commonly used mechanism. The heptanucleotide consensus is X XXY YYZ (10), however a large number of functional variations to this have been documented (described in 11). Since the mammalian 55S mitoribosome differs in a number of ways from the bacterial 70S and eukaryotic 80S counterparts (12) , the requirement for, position and the characteristics of a slippery sequence may be different. In particular it is important to note that the A, P and E-site tRNAs are all reported to be involved in viral PRF (13) .
However, no conventional E site is believed to exist in mitoribosomes (12) , reducing both the number and hence overall strength of codon/anticodon interactions. Further, as human mitochondrial translation uses only 22 mt-tRNAs to recognize 60 codons, mt-tRNAs generate a looser codon:anticodon interaction than other systems by using a "2 out of 3" base interaction (14) . Finally, when the A-site is occupied by an AGA or AGG codon there will be no corresponding mt-tRNA. Therefore, in contrast with conventional -1PRF, only a weak mt-mRNA/mt-tRNA interaction will need to be broken to allow reformation in the -1 frame.
With respect to the downstream element, it has been reported that such features act as positive modulators to significantly improve efficiency of poor heptanucleotide sequences (15) . Although human mtDNA is remarkably concise and the derived transcripts are often depicted as having no untranslated regions, this is not entirely correct. In the case of MTCO1 the putative terminal AGA is followed by the antisense of tRNA ser (UCN) that is generally not cleaved on processing (16) . Similarly, the AGG of MTND6 is followed by UTRs of various lengths that extend into the antisense of MTND5 (16) . Using folding algorithms (17), the antisense tRNA ser (UCN) is predicted to generate a stable cloverleaf similar to a tRNA, and the sequence immediately downstream of MTND6 is predicted to form a stem loop (Fig 1) . This bioinformatic data supports the hypothesis that MTCO1 and MTND6 transcripts contain features that can promote a -1 frameshift. - 
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Can -1 frameshifting be demonstrated on human mtRNA? To experimentally determine whether -1 frameshifting occurs in human mitochondria, we attempted to fine map the precise sequence of the MTCO1 termination codon. For this we constructed a mitochondrially targeted version of RelE (mtRelE, 18) , an endoribonuclease that has previously been shown to specifically cleave RNA occupying the A site of the bacterial ribosome. Further, this enzyme shows marked sequence preference for the standard termination codons UAG and UAA. Human HEK293T cells were prepared to inducibly express mtRelE (18) , which was efficiently localised and imported into the mitochondrial matrix as evidenced by protection from protease digestion after removal of the outer mitochondrial membrane ( Fig S1) .
RelE has very distinct sequence selectivity; UAG is the preferred substrate, followed by UAA, with negligible predicted recognition of AGA/AGG and non detectable K cat /K m values for AGA (18) . This would infer that production of COX1 and ND6 whose ORFs putatively terminate in AGA/AGG should be unaffected. Global effects on mitochondrial translation were, therefore, assessed by metabolic labelling (S 35 -met) of wildtype and mtRelE induced cells (19) . Strikingly, however, de novo synthesis of most mt-proteins including COX1 and ND6 was robustly reduced (Fig2A). Northern analysis of control cells post mtRelE expression revealed the majority of MTCO1 (68 ± 1.73 %, n=3) and MTCO2 (70 ± 1.4 %, n=3) transcripts to be intact at steady state (Fig2B lanes 1 and 3) . Hence, the loss of de novo protein synthesis could not be attributed to non-specific degradation of transcripts by mtRelE. Depletion of the endogenous mitochondrial release factor mtRF1a, is known to stabilise transcripts possibly through an extended association of the mt-mRNA with the mitoribosome. RelE expression promotes release of cleaved mRNA from the bacterial ribosome (18) . Therefore, mtRelE expression would be predicted to release cleaved transcripts from the mitoribosome abrogating mitoribosome mediated protection. To initiate the fine mapping of the mtRelE cleavage site in mt-mRNAs we first analysed MTCO2 as it terminates in the preferred UAG and would be predicted to lose its short (25 nt) 3'UTR on mtRelE cleavage. Analysis by tail length assay indicated full-length polyadenylated transcripts in wildtype cells (Fig2C lanes 1-4) . Processing of L-strand transcript 3' termini in vivo normally leads to oligo-or polyadenylation (20) . Consistent with this, a second population of shorter species of a length approximating to readenylated truncated transcripts, became evident post mtRelE induction (Fig2C lanes 5-8) . To reveal the cleavage site, truncated species were sequenced after ligation mediated RT-PCR (LM RT-PCR, 19) and subsequent cloning. All sequences confirmed specific removal of the 3'UTR followed by readenylation (Fig2C). However, since MTCO2 uses UAG as a stop codon, cleavage between either positions 1/2 or 2/3 within the codon would generate UAAA n , making it impossible to identify whether cleavage had occurred after nucleotide 1 or 2. The same problem would be encountered with the UAA codons, which constitute 9 of the 13 termination codons in human mitochondria.
As shown in
To resolve the issue of positional cleavage within the triplet we examined RNA14 the bicistronic unit with overlapping ORFs, reasoning that cleavage of the upstream MTATP8 UAG codon would release a stable downstream cleavage product. By mapping the 5' termini of this species the precise mtRelE cleavage position would be revealed. Northern analysis indicated that post mtRelE induction greater than 90% of the remaining MTRNA14 However, to finally confirm that MTCO1 uses UAG and not AGA as a termination codon, we cloned and sequenced LM RT-PCR generated products of MTCO1 post-cleavage. As mtRelE cleaves only between the 2 nd and 3 rd nucleotides of the stop codon, a prediction can be made following mtRelE expression ; use of AGA as termination codon would result in -AAAAUCUAGA n whilst UAG would produce -AAAAUCUAA n . RNA from control cells was analysed, 10 of the 12 clones reflected the predicted full-length MTCO1 transcript containing the 3'UTR, the remaining 2 were partial truncations in the antisense tRNA Ser , commonly identified in the EST database. This species was also found in 2 of the mtRelE samples. All of the remaining 33 mtRelE clones however, terminated in -AAAAUCUA followed by readenylation (Fig3B), signifying that MTCO1 terminates at UAG rather than AGA.
In conclusion, human mitochondria invoke -1 frameshifting. This is facilitated by mitoribosomes stalling at AGA/AGG codons for which there are no cognate mt-tRNAs, potentially in concert with diminished upstream codon/anticodon interactions due to a nonconventional E-site, and a secondary structure immediately downstream. In the absence of methods by which mammalian mitochondria can be transfected the contribution of these 5' and 3' elements cannot be interrogated. We have however, used a mitochondrially targeted endoribonuclease, mtRelE to confirm a mitoribosome shuffle that shunts the AGA/AGG from the A-site replacing them with the conventional stop codon, UAG. Perhaps Panel A depicts a cartoon of the characterised elements that promote PRF; an upstream slippery sequence (10, 11) , a rare 'hungry' codon (8, 9) and a stable secondary structure downstream (12) . Variations on these elements are present in mitochondrial transcripts MTCO1 (B) and MTND6 (C) (see text). 
